I'm joined this week by my friend Ross Rheingans-Yoo, who has had an eclectic career, most recently in investment in pharmaceutical R&D. We chatte

From molecule to medicine, with Ross Rheingans-Yoo

submited by

Style Pass

2024-10-31 21:30:05

I'm joined this week by my friend Ross Rheingans-Yoo, who has had an eclectic career, most recently in investment in pharmaceutical R&D. We chatted about what the lifecycle of drugs is, how trials are regulated by the FDA in the U.S. (and what the history is there), and how processes with many well-credentialed PhDs, lives hanging in the balance, and billions of dollars on the line are sometimes surprisingly unoptimized.

[Patrick notes: I add inline observations to the transcript after the recording of the conversation, set out in this fashion. As always, transcripts at Complex Systems are not stenographed for literally reproducing the conversation, but are edited (including by an AI this time) with an eye to producing the best readable version of a spoken conversation.]

Manifold is my favorite prediction market platform, making it easy to bet on anything from elections to crypto drama. Get started with a bonus at https://manifold.markets/complexsystems when you spend $20. Play money markets open to anyone; cash prizes only available to U.S. residents of at least 18 years of age. Terms and conditions apply.